Intrinsic Advisors, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- HQ
- PA
Intrinsic Advisors, LLC is a growth-equity investment firm. It focuses on scalable life science and technology-focused businesses within the alternative therapeutics market.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Growth | Not enough dated deals | None |
| Sectors | Not stated | Not enough dated deals | None |
| Regions | Not stated | Not enough dated deals | None |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2018 | 1 | Ecommerce |
| 2019 | 1 | Biotech, Healthtech, Medical devices |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Intrinsic Investments Fund I, L.P. | approx. 2024 | $17.5M (Form D) | Open, writing first checks |
| INTRINSIC HEALTH PARTNERS II, L.P. | 2022 | $62.37M (Form D) | Open, writing first checks |
03 · People across funds
- Christopher Jung, Chief Financial Officer of Issuer's General Partner
INTRINSIC HEALTH PARTNERS II, L.P. (Named on Form D)
- Cornelius Merlini, Managing Member of Issuer's General Partner
INTRINSIC HEALTH PARTNERS II, L.P. (Named on Form D)
- Daniel Rubin, Managing Director of the General Partner of the Issuer
Intrinsic Investments Fund I, L.P. (Named on Form D)
- Gerald Stahlecker III, Managing Member of Issuer's General Partner
INTRINSIC HEALTH PARTNERS II, L.P. (Named on Form D)
- Howard Goodwin M.D., Managing Member of Issuer's General Partner
INTRINSIC HEALTH PARTNERS II, L.P. (Named on Form D)
- Johannes Froehling, Managing Director of the General Partner of the Issuer
Intrinsic Investments Fund I, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026